Ad is loading...
IDYA
Price
$26.79
Change
+$0.19 (+0.71%)
Updated
Nov 22, 03:46 PM (EDT)
130 days until earnings call
IONS
Price
$34.37
Change
+$0.43 (+1.27%)
Updated
Nov 22, 03:26 PM (EDT)
89 days until earnings call
Ad is loading...

IDYA vs IONS

Header iconIDYA vs IONS Comparison
Open Charts IDYA vs IONSBanner chart's image
IDEAYA Biosciences
Price$26.79
Change+$0.19 (+0.71%)
Volume$600
CapitalizationN/A
Ionis Pharmaceuticals
Price$34.37
Change+$0.43 (+1.27%)
Volume$654
CapitalizationN/A
IDYA vs IONS Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IDYA vs. IONS commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Hold and IONS is a Sell.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (IDYA: $26.60 vs. IONS: $33.94)
Brand notoriety: IDYA and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 200% vs. IONS: 138%
Market capitalization -- IDYA: $2.21B vs. IONS: $5.59B
IDYA [@Biotechnology] is valued at $2.21B. IONS’s [@Biotechnology] market capitalization is $5.59B. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, IDYA is a better buy in the long-term than IONS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 4 TA indicator(s) are bullish while IONS’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 4 bullish, 4 bearish.
  • IONS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IONS is a better buy in the short-term than IDYA.

Price Growth

IDYA (@Biotechnology) experienced а -9.74% price change this week, while IONS (@Biotechnology) price change was -8.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.18%. For the same industry, the average monthly price growth was -4.97%, and the average quarterly price growth was +4.04%.

Reported Earning Dates

IDYA is expected to report earnings on Apr 01, 2025.

IONS is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Biotechnology (+2.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IONS($5.59B) has a higher market cap than IDYA($2.21B). IDYA YTD gains are higher at: -25.239 vs. IONS (-32.912). IDYA has higher annual earnings (EBITDA): -220.54M vs. IONS (-249.52M). IONS has more cash in the bank: 2.48B vs. IDYA (920M). IDYA has less debt than IONS: IDYA (18.8M) vs IONS (1.45B). IONS has higher revenues than IDYA: IONS (803M) vs IDYA (3.92M).
IDYAIONSIDYA / IONS
Capitalization2.21B5.59B39%
EBITDA-220.54M-249.52M88%
Gain YTD-25.239-32.91277%
P/E RatioN/AN/A-
Revenue3.92M803M0%
Total Cash920M2.48B37%
Total Debt18.8M1.45B1%
FUNDAMENTALS RATINGS
IONS: Fundamental Ratings
IONS
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
80
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIONS
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
72%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
71%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
75%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 3 days ago
62%
Declines
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 5 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DNDGX20.530.48
+2.39%
Dunham Small Cap Growth N
CDIRX35.640.36
+1.02%
Columbia Dividend Income R
FWCFX37.110.23
+0.62%
Fidelity Advisor Worldwide C
GENIX15.20N/A
N/A
Gotham Enhanced Return Institutional
OAZWX22.77-0.01
-0.04%
Oakmark Global Select R6

IONS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with ALNY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then ALNY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
-4.12%
ALNY - IONS
48%
Loosely correlated
-0.80%
AXON - IONS
43%
Loosely correlated
+3.52%
PGEN - IONS
38%
Loosely correlated
+7.91%
ARWR - IONS
37%
Loosely correlated
-2.30%
IDYA - IONS
37%
Loosely correlated
+4.15%
More